Can Fite Biopharma
CANF
$2.36
Share price
0.00%
Change (1 day)
-8.53%
Change (1 year)
Categories
Can Fite Biopharma (CANF) - P/B ratio
P/B ratio as of June 2024 : 1.89
According to Can Fite Biopharma
's latest financial reports the company has a price-to-book ratio of 1.89.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Can Fite Biopharma - P/B ratio (from 2012 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.25 | -44.94% |
| 2022-12-31 | 4.08 | 81.51% |
| 2021-12-31 | 2.25 | -52.22% |
| 2020-12-31 | 4.71 | -11.82% |
| 2019-12-31 | 5.34 | -35.38% |
| 2018-12-31 | 8.26 | 68.03% |
| 2017-12-31 | 4.91 | -42.26% |
| 2016-12-31 | 8.51 | 118.1% |
| 2015-12-31 | 3.90 | -29.24% |
| 2014-12-31 | 5.52 | -45.42% |
| 2013-12-31 | 10.1 | -129.36% |
| 2012-12-31 | -34.4 | |
| 2011-12-31 | N/A |